Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Morphine	O
/	O
Codeine	O
/	O
Keflex	O
/	O
Iodine-Iodine	O
Containing	O
/	O
Tetracycline	O
/	O
Lipitor	O
/	O
Ace	O
Inhibitors	O
/	O
Glyburide	O
/	O
Metformin	O
/	O
Clonidine	O
/	O
Percocet	O
/	O
Benadryl	O
/	O
Flovent	O
Diskus	O
/	O
Spiriva	O
with	O
HandiHaler	O
/	O
hydralazine	O
/	O
chlorthalidone	O
Attending:	O
___	O
Chief	O
Complaint:	O
Nausea,	O
vomiting	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
female	O
with	O
AF	O
on	O
apixaban,	O
HFpEF	O
followed	O
by	O
___,	O
AS,	O
MR,	O
CAD	O
s/p	O
DES	O
x2	O
RCA	O
stent	O
___,	O
tachy/___	O
syndrome	O
s/p	O
PPM	O
___,	O
DM,	O
HTN,	O
HLD,	O
PVD,	O
CKD,	O
and	O
COPD	O
who	O
presents	O
with	O
nausea	O
and	O
vomiting	O
with	O
concomitant	O
weight	O
gain.	O
Patient	O
was	O
seen	O
on	O
___	O
in	O
the	O
heart	O
failure	O
clinic	O
where	O
she	O
was	O
noted	O
to	O
have	O
a	O
weight	O
gain	O
of	O
10lbs	O
over	O
a	O
few	O
months.	O
As	O
a	O
result,	O
she	O
was	O
sent	O
to	O
the	O
___	O
for	O
IV	O
furosemide	O
100mg	O
x1	O
and	O
continued	O
on	O
torsemide	O
40mg	O
(increased	O
on	O
___	O
from	O
furosemide	O
40mg).	O
She	O
reports	O
that	O
she	O
lost	O
1lb	O
with	O
that	O
diuresis	O
but	O
subsequently	O
gained	O
it	O
back	O
the	O
following	O
day.	O
Two	O
nights	O
prior	O
to	O
presentation,	O
she	O
developed	O
acute	O
onset	O
nausea,	O
diaphoresis,	O
and	O
"wooziness,"	O
which	O
upon	O
further	O
questioning	O
the	O
patient	O
stating	O
felt	O
somewhat	O
like	O
lightheadedness.	O
In	O
the	O
ED,	O
she	O
reported	O
that	O
this	O
may	O
have	O
been	O
associated	O
with	O
some	O
chest	O
pressure	O
though	O
she	O
did	O
not	O
think	O
so	O
by	O
the	O
time	O
she	O
got	O
to	O
the	O
floor.	O
She	O
denies	O
dyspnea,	O
arm	O
pain,	O
and	O
jaw	O
pain.	O
The	O
episode	O
was	O
self	O
resolving	O
after	O
a	O
few	O
minutes	O
She	O
had	O
another	O
similar	O
episode	O
on	O
the	O
night	O
of	O
presentation	O
that	O
was	O
also	O
associated	O
with	O
emesis	O
and	O
mild	O
chest	O
pressure	O
(without	O
radiation).	O
It	O
again	O
resolved	O
within	O
a	O
few	O
minutes.	O
This	O
prompted	O
her	O
to	O
present	O
to	O
the	O
ED.	O
In	O
the	O
ED,	O
-	O
Vital	O
signs	O
-	O
T	O
max	O
97.8,	O
BP	O
___	O
and	O
satting	O
well	O
on	O
room	O
air.	O
-	O
Exam	O
-	O
notable	O
for	O
flat	O
neck	O
veins,	O
diffuse	O
crackles	O
in	O
the	O
posterior	O
lung	O
fields,	O
and	O
2+	O
pitting	O
edema	O
bilaterally.	O
-	O
ECG	O
-	O
atrial	O
paced	O
rhythm	O
at	O
60	O
BPM	O
with	O
poor	O
R	O
wave	O
progression	O
though	O
without	O
ST	O
changes	O
to	O
suggest	O
acute	O
ischemia.	O
-	O
CXR	O
-	O
stable	O
chronic	O
interstitial	O
abnormality	O
without	O
acute	O
intrathoracic	O
process.	O
-	O
Labs	O
-	O
notable	O
for	O
proBNP	O
1396,	O
Cr	O
2.8	O
(recently	O
uptrending),	O
BUN	O
111,	O
and	O
troponins	O
<0.01	O
x1.	O
-	O
UA	O
-	O
large	O
___,	O
20	O
WBC<	O
and	O
few	O
bacteria.	O
On	O
the	O
floor,	O
the	O
patient	O
confirms	O
the	O
above	O
history.	O
She	O
denies	O
any	O
recent	O
sick	O
contacts	O
or	O
infectious	O
symptoms	O
(including	O
fevers,	O
chills,	O
diarrhea).	O
REVIEW	O
OF	O
SYSTEMS:	O
Cardiac	O
review	O
of	O
systems	O
is	O
notable	O
for	O
absence	O
of	O
chest	O
pain,	O
dyspnea	O
on	O
exertion,	O
paroxysmal	O
nocturnal	O
dyspnea,	O
orthopnea,	O
ankle	O
edema,	O
palpitations,	O
syncope,	O
or	O
presyncope.	O
On	O
further	O
review	O
of	O
systems,	O
denies	O
any	O
prior	O
history	O
of	O
stroke,	O
TIA,	O
deep	O
venous	O
thrombosis,	O
pulmonary	O
embolism,	O
bleeding	O
at	O
the	O
time	O
of	O
surgery,	O
myalgias,	O
joint	O
pains,	O
cough,	O
hemoptysis,	O
black	B-Upper_gastrointestinal_haemorrhage
stools	B-Upper_gastrointestinal_haemorrhage
or	O
red	B-Lower_gastrointestinal_haemorrhage
stools.	B-Lower_gastrointestinal_haemorrhage
Denies	O
exertional	O
buttock	O
or	O
calf	O
pain.	O
Denies	O
recent	O
fevers,	O
chills	O
or	O
rigors.	O
All	O
of	O
the	O
other	O
review	O
of	O
systems	O
were	O
negative.	O
Past	O
Medical	O
History:	O
-CAD:	O
s/p	O
D1	O
(___),	O
OM1	O
(___),	O
and	O
proximal	O
RCA	O
(___)	O
stents.	O
-PAD	O
status	O
post	O
multiple	O
peripheral	O
vascular	O
interventions	O
in	O
the	O
right	O
superficial	O
femoral	O
artery.	O
___	O
peripheral	O
angiogram	O
in	O
her	O
LLE,	O
with	O
subsequent	O
two	O
stents	O
to	O
L	O
SFA.	O
s/p	O
R	O
-CIA	O
stent	O
w/	O
R	O
EIA	O
___	O
stenosis.	O
Aorta	O
has	O
diffuse	O
atherosclerosis.	O
-Moderate	O
non	O
proliferative	O
diabetic	O
retinopathy	O
bilaterally	O
-Interstitial	O
lung	O
disease,	O
suspected	O
fibrotic	O
NSIP	O
versus	O
chronic	O
HP	O
-Atrial	O
fibrillation	O
on	O
warfarin	O
c/b	O
tachy-brady	O
syndrome	O
s/p	O
PPM	O
-dCHF	O
(EF	O
70%	O
___	O
-DMII	O
-HTN	O
-Hypothyroidism	O
-Allergic	O
rhinitis	O
-Hyperlipidemia	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
Admission	O
Exam:	O
VITALS:	O
97.8	O
158/34	O
60	O
16	O
95%RA	O
GENERAL:	O
Well-developed	O
elderly	O
female	O
laying	O
comfortably	O
in	O
bed.	O
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthelasma.	O
NECK:	O
Supple	O
with	O
JVP	O
of	O
elevated	O
to	O
15-20	O
cm	O
(just	O
under	O
angle	O
of	O
the	O
jaw)	O
CARDIAC:	O
RRR,	O
normal	O
S1/S2,	O
no	O
murmurs,	O
rubs,	O
or	O
gallops.	O
III/VI	O
systolic	O
murmur	O
appreciated	O
___	O
at	O
the	O
upper	O
sternal	O
borders	O
with	O
radiation	O
to	O
the	O
carotids	O
bilaterally	O
and	O
the	O
back.	O
S2	O
is	O
audible.	O
LUNGS:	O
Coarse	O
bibasilar	O
crackles.	O
No	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM	O
or	O
tenderness.	O
EXTREMITIES:	O
No	O
c/c/e.	O
No	O
femoral	O
bruits.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	O
scars,	O
or	O
xanthomas.	O
PULSES:	O
Distal	O
pulses	O
palpable	O
and	O
symmetric	O
Discharge	O
Exam:	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
725)	O
Temp:	O
98.2	O
(Tm	O
99.0),	O
BP:	O
137/62	O
(124-155/42-91),	O
HR:	O
62	O
(59-67),	O
RR:	O
18	O
(___),	O
O2	O
sat:	O
98%	O
(95-100),	O
O2	O
delivery:	O
RA,	O
Wt:	O
179.23	O
lb/81.3	O
kg	O
___	O
Total	O
Output:	O
250ml	O
Urine	O
Amt:	O
250ml	O
GENERAL:	O
Well-developed	O
female	O
sitting	O
upright	O
comfortably	O
in	O
bed.	O
NAD.	O
Mood,	O
affect	O
appropriate.	O
HEENT:	O
PERRL,	O
MMM	O
NECK:	O
Supple	O
with	O
JVP	O
at	O
clavicle	O
at	O
90	O
degrees	O
CARDIAC:	O
RRR,	O
normal	O
S1/S2,	O
III/VI	O
systolic	O
crescendo-decrescendo	O
murmur	O
appreciated	O
___	O
at	O
the	O
upper	O
sternal	O
borders.	O
S2	O
is	O
audible.	O
LUNGS:	O
Coarse	O
bibasilar	O
crackles.	O
No	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Soft,	O
NTND.	O
EXTREMITIES:	O
Mildly	O
tender	O
trace	O
lower	O
extremity	O
edema	O
to	O
bilateral	O
mid-shin.	O
No	O
femoral	O
bruits.	O
SKIN:	O
Warm,	O
well-perfused	O
PULSES:	O
Distal	O
pulses	O
palpable	O
and	O
symmetric	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
===============	O
___	O
10:12AM	O
cTropnT-<0.01	O
___	O
12:28AM	O
cTropnT-<0.01	O
___	O
02:05AM	O
URINE	O
COLOR-Straw	O
APPEAR-Clear	O
SP	O
___	O
___	O
02:05AM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-NEG	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.0	O
LEUK-LG*	O
___	O
02:05AM	O
URINE	O
RBC-1	O
WBC-20*	O
BACTERIA-FEW*	O
YEAST-NONE	O
EPI-<1	O
___	O
12:28AM	O
GLUCOSE-134*	O
UREA	O
N-111*	O
CREAT-2.8*	O
SODIUM-137	O
POTASSIUM-4.6	O
CHLORIDE-99	O
TOTAL	O
CO2-25	O
ANION	O
GAP-13	O
___	O
12:28AM	O
___	O
PTT-33.9	O
___	O
___	O
12:28AM	O
NEUTS-65.8	O
LYMPHS-15.0*	O
MONOS-12.3	O
EOS-6.1	O
BASOS-0.4	O
IM	O
___	O
AbsNeut-4.61	O
AbsLymp-1.05*	O
AbsMono-0.86*	O
AbsEos-0.43	O
AbsBaso-0.03	O
___	O
12:28AM	O
proBNP-1396*	O
___	O
12:28AM	O
ALT(SGPT)-11	O
AST(SGOT)-12	O
ALK	O
PHOS-91	O
TOT	O
BILI-0.3	O
___	O
12:28AM	O
LIPASE-69*	O
DISCHARGE	O
LABS:	O
===============	O
___	O
06:40AM	O
BLOOD	O
WBC-7.7	O
RBC-3.74*	O
Hgb-11.2	O
Hct-34.5	O
MCV-92	O
MCH-29.9	O
MCHC-32.5	O
RDW-12.4	O
RDWSD-42.1	O
Plt	O
___	O
___	O
06:40AM	O
BLOOD	O
Glucose-161*	O
UreaN-107*	O
Creat-2.4*	O
Na-140	O
K-4.0	O
Cl-101	O
HCO3-22	O
AnGap-17	O
STUDIES:	O
========	O
___:	O
RHC	O
-	O
RA	O
2,	O
RV	O
40/2,	O
PA	O
22,	O
PCWP	O
13	O
1.	O
Low	O
RA	O
and	O
only	O
mildly	O
elevated	O
PCW	O
pressures,	O
with	O
normal	O
right	O
ventricular	O
end-diastolic	O
pressure.	O
2.	O
Normal	O
calculated	O
cardiac	O
index.	O
3.	O
Mild	O
pulmonary	O
systolic	O
hypertension.	O
___	O
TTE:	O
LVEF	O
75%.	O
Severe	O
aortic	O
stenosis	O
by	O
continuity	O
equation	O
(visually	O
the	O
leaflets	O
appear	O
more	O
pliable	O
and	O
consistent	O
with	O
moderate	O
aortic	O
stenosis).	O
Vigorous	O
biventricular	O
systolic	O
function.	O
Borderline	O
pulmonary	O
hypertension.	O
___	O
CXR:	O
1.	O
No	O
acute	O
intrathoracic	O
process.	O
2.	O
Stable	O
chronic	O
interstitial	O
abnormality.	O
___	O
ECG:	O
Atrial-paced	O
rhythm	O
late	O
rwp	O
Anterior	O
infarct,	O
old	O
compared	O
to	O
previous	O
ECG	O
No	O
significant	O
change	O
was	O
found	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
female	O
with	O
a	O
multitude	O
of	O
cardiac	O
issues	O
most	O
notable	O
for	O
HFpEF	O
___	O
LVEF	O
75%,	O
LVH),	O
mod-severe	O
AS,	O
CAD	O
s/p	O
PCI,	O
tachy-brady	O
syndrome	O
s/p	O
PPM	O
on	O
apixaban,	O
and	O
HTN/HLD/DM/COPD	O
presents	O
with	O
two	O
episodes	O
of	O
transient	O
nausea/vomiting/diaphoresis	O
in	O
the	O
setting	O
of	O
a	O
subacute	O
heart	O
failure	O
exacerbation.	O
TRANSITIONAL	O
ISSUES	O
===================	O
[	O
]	O
Follow-up	O
with	O
outpatient	O
cardiology	O
for	O
possible	O
aortic	O
valve	O
replacement.	O
Patient	O
found	O
to	O
have	O
severe	O
aortic	O
stenosis,	O
largely	O
unchanged	O
since	O
___	O
TTE.	O
[	O
]	O
Check	O
Cr	O
in	O
one	O
week.	O
[	O
]	O
Follow-up	O
on	O
diabetes	O
management.	O
Patient	O
was	O
on	O
SSI	O
during	O
admission	O
with	O
BGs	O
in	O
mid-high	O
200s.	O
-	O
Discharge	O
weight:	O
179.2	O
lb,	O
discharge	O
Cr:	O
2.4	O
-	O
Patient	O
was	O
evaluated	O
by	O
physical	O
therapy	O
with	O
recommendation	O
for	O
discharge	O
to	O
rehab,	O
which	O
patient	O
declined.	O
She	O
was	O
offered	O
home	O
physical	O
therapy	O
on	O
discharge.	O
ACTIVE	O
ISSUES	O
=============	O
#	O
Subacute	O
on	O
chronic	O
HFpEF	O
___	O
LVEF	O
75%)	O
Weight	O
gain	O
had	O
been	O
ongoing	O
for	O
several	O
weeks-months	O
and	O
diuresis	O
as	O
an	O
outpatient	O
has	O
been	O
limited	O
by	O
rising	O
Cr	O
in	O
the	O
setting	O
of	O
CKD.	O
He	O
was	O
diuresed	O
with	O
IV	O
Lasix	O
in	O
the	O
CDAC	O
last	O
week	O
without	O
significant	O
improvement	O
in	O
weights,	O
symptoms.	O
Initially	O
diuresed	O
with	O
Lasix	O
120	O
BID	O
this	O
admission,	O
though	O
discontinued	O
diuresis	O
on	O
___	O
due	O
to	O
Cr	O
elevations.	O
Home	O
carvedilol	O
50	O
mg	O
BID	O
continued,	O
and	O
home	O
losartan	O
discontinued	O
in	O
setting	O
of	O
___.	O
Patient	O
had	O
euvolemic	O
exam	O
prior	O
to	O
discharge.	O
TTE	O
on	O
___	O
showed	O
severe	O
AS	O
and.	O
___	O
RHC	O
showed	O
RA	O
2,	O
RV	O
40/2,	O
PA	O
22,	O
PCWP	O
13,	O
and	O
mild	O
pulmonary	O
systolic	O
hypertension.	O
#	O
Nausea,	O
vomiting	O
#	O
Dizziness	O
Patient	O
presented	O
complaining	O
of	O
episodes	O
of	O
N/V	O
and	O
dizziness.	O
No	O
arrhythmias	O
noted	O
on	O
telemetry,	O
and	O
pacemaker	O
interrogation	O
on	O
___	O
showed	O
no	O
events.	O
Low	O
concern	O
for	O
infectious	O
etiology.	O
Patient	O
had	O
positive	O
orthostatic	O
vital	O
signs	O
during	O
admission,	O
likely	O
in	O
the	O
setting	O
of	O
overdiuresis.	O
Episodes	O
may	O
also	O
be	O
explained	O
by	O
patient's	O
moderate-severe	O
aortic	O
stenosis.	O
#	O
___	O
on	O
CKD	O
Cr	O
uptrending	O
over	O
the	O
past	O
6	O
months	O
from	O
2.0	O
to	O
high	O
2-low	O
3.	O
Initially	O
uptrended	O
with	O
diuresis	O
as	O
high	O
as	O
3.0.	O
Cr	O
downtrended	O
to	O
2.4	O
prior	O
to	O
discharge	O
in	O
the	O
setting	O
of	O
holding	O
diuresis	O
(___-).	O
#	O
Hypertension	O
Antihypetensive	O
regimen	O
had	O
recently	O
been	O
adjusted	O
as	O
an	O
outpatient,	O
complicated	O
by	O
uptrending	O
Cr.	O
Losartan	O
discontinued	O
___	O
due	O
to	O
___.	O
Increased	O
home	O
carvedilol	O
to	O
50	O
mg	O
BID	O
and	O
continued	O
home	O
amlodipine	O
10	O
mg	O
as	O
an	O
inpatient.	O
CHRONIC/STABLE	O
ISSUES:	O
=====================	O
#	O
Mod-Severe	O
AS	O
Recent	O
TTE	O
with	O
EF	O
75%	O
and	O
aortic	O
velocity	O
3.6m/sec.	O
Per	O
outpatient	O
notes,	O
some	O
discrepancy	O
between	O
recent	O
TTEs	O
with	O
regard	O
to	O
moderate	O
or	O
severe	O
AS.	O
#	O
CAD	O
s/p	O
PCI	O
Most	O
recently	O
with	O
DES	O
x2	O
to	O
RCA	O
in	O
___.	O
Patient	O
denied	O
chest	O
pain	O
symptoms.	O
Continued	O
pravastatin,	O
carvedilol	O
and	O
aspirin	O
during	O
admission.	O
Ranexa	O
was	O
discontinued.	O
#	O
Tachy/___	O
syndrome	O
s/p	O
PPM	O
History	O
of	O
atrial	O
fibrillation	O
now	O
s/p	O
PPM	O
in	O
___.	O
No	O
events	O
on	O
pacemaker	O
interrogation	O
___.	O
Apixiban	O
held	O
___	O
prior	O
to	O
RHC.	O
Carvedilol	O
continued	O
throughout	O
admission.	O
#	O
COPD/interstitial	O
lung	O
disease	O
Followed	O
by	O
Dr.	O
___.	O
Anoro	O
ellipta	O
nonformulary,	O
so	O
combivent	O
given	O
during	O
this	O
admission.	O
Albuterol	O
PRN	O
continued	O
during	O
admission.	O
#	O
Hypothyroidism	O
Continued	O
levothyroxine	O
100mcg	O
daily	O
#	O
DMII	O
Diet	O
controlled.	O
A1c	O
6.6	O
on	O
presentation.	O
On	O
SSI	O
during	O
admission.	O
#	O
PVD	O
Continued	O
home	O
aspirin,	O
statin.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
2.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q4H:PRN	O
dyspnea	O
3.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
dyspnea	O
4.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
5.	O
Apixaban	O
2.5	O
mg	O
PO	O
BID	O
6.	O
Benzonatate	O
100	O
mg	O
PO	O
QHS:PRN	O
cough	O
7.	O
CARVedilol	O
37.5	O
mg	O
PO	O
BID	O
8.	O
Gabapentin	O
100-300	O
mg	O
PO	O
QHS	O
9.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
10.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
11.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
12.	O
Ranitidine	O
150	O
mg	O
PO	O
BID	O
13.	O
Ranexa	O
(ranolazine)	O
500	O
mg	O
oral	O
BID	O
14.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
15.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Cream	O
1	O
Appl	O
TP	O
TID	O
16.	O
Anoro	O
Ellipta	O
(umeclidinium-vilanterol)	O
62.5-25	O
mcg/actuation	O
inhalation	O
DAILY	O
17.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
18.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
19.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
20.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
21.	O
PreserVision	O
Lutein	O
(vit	O
C-vit	O
E-copper-zinc-lutein)	O
226	O
mg-200	O
unit	O
-5	O
mg-0.8	O
mg	O
oral	O
BID	O
Discharge	O
Medications:	O
1.	O
Torsemide	O
20	O
mg	O
PO	O
DAILY-	O
on	O
hold	O
until	O
evaluated	O
by	O
___	O
team	O
2.	O
CARVedilol	O
50	O
mg	O
PO	O
BID	O
3.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q4H:PRN	O
dyspnea	O
4.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
dyspnea	O
5.	O
amLODIPine	O
10	O
mg	O
PO	O
DAILY	O
6.	O
Anoro	O
Ellipta	O
(umeclidinium-vilanterol)	O
62.5-25	O
mcg/actuation	O
inhalation	O
DAILY	O
7.	O
Apixaban	O
2.5	O
mg	O
PO	O
BID	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
Benzonatate	O
100	O
mg	O
PO	O
QHS:PRN	O
cough	O
10.	O
Cetirizine	O
10	O
mg	O
PO	O
DAILY	O
11.	O
Gabapentin	O
100-300	O
mg	O
PO	O
QHS	O
12.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
13.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
14.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
15.	O
Pravastatin	O
80	O
mg	O
PO	O
QPM	O
16.	O
PreserVision	O
Lutein	O
(vit	O
C-vit	O
E-copper-zinc-lutein)	O
226	O
mg-200	O
unit	O
-5	O
mg-0.8	O
mg	O
oral	O
BID	O
17.	O
Ranitidine	O
150	O
mg	O
PO	O
BID	O
18.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Cream	O
1	O
Appl	O
TP	O
TID	O
19.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
20.	O
HELD-	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Losartan	O
Potassium	O
until	O
you	O
follow-up	O
with	O
your	O
PCP.	O
Discharge	O
Disposition:	O
Home	B-Has_carers
With	B-Has_carers
Service	B-Has_carers
Facility:	O
___	O
___:	O
HFpEF	O
exacerbation	O
Acute	O
on	O
Chronic	O
kidney	O
disease	O
Moderate	O
aortic	O
stenosis	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___	O
___.	O
WHY	O
WAS	O
I	O
ADMITTED	O
TO	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
you	O
were	O
found	O
to	O
be	O
volume	O
overloaded	O
due	O
to	O
a	O
heart	O
failure	O
exacerbation.	O
WHAT	O
HAPPENED	O
WHILE	O
I	O
WAS	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
given	O
medication	O
through	O
the	O
veins	O
to	O
help	O
bring	O
down	O
the	O
fluid.	O
-	O
An	O
ultrasound	O
of	O
your	O
heart	O
showed	O
hardening	O
of	O
one	O
of	O
the	O
valves.	O
-	O
A	O
study	O
of	O
the	O
right	O
side	O
of	O
the	O
heart	O
showed	O
no	O
significant	O
abnormalities.	O
-	O
You	O
were	O
found	O
to	O
have	O
decreased	O
kidney	O
function	O
due	O
to	O
dehydration.	O
WHAT	O
SHOULD	O
I	O
DO	O
WHEN	O
I	O
GO	O
HOME?	O
-	O
You	O
should	O
continue	O
to	O
take	O
your	O
medications	O
as	O
prescribed.	O
-	O
You	O
should	O
attend	O
the	O
appointments	O
listed	O
below.	O
-	O
Please	O
return	O
to	O
the	O
emergency	O
room	O
if	O
you	O
have	O
severe	O
chest	O
pain,	O
worsening	O
shortness	O
of	O
breath,	O
or	O
loss	O
of	O
consciousness.	O
We	O
wish	O
you	O
the	O
___!	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

